Literature DB >> 14504624

Adverse events and patients' perceptions of antihypertensive drug effectiveness.

S Svensson1, K I Kjellgren.   

Abstract

Adverse events that patients attribute to their drug treatment are generally considered to reduce adherence to medication. However, some patients interpret such symptoms as indicating drug effectiveness. If perceivedly effective drugs are more likely to be taken then adverse events may increase adherence. The extent to which patients interpret adverse events as indicating drug effectiveness is not well known. We investigated this in a cross-sectional questionnaire study of 1013 drug-treated hypertensive patients from 55 primary health-care centres and 11 internal medicine clinics in Sweden. We hypothesized that estimates of future risk of complications of hypertension made by hypertensive patients who had adverse events would be lower than estimates made by patients who did not have adverse events, and that these estimates would only differ when patients were estimating their risks in a setting where they continued taking antihypertensive drugs. Patients' risk estimates were measured with visual analogue scales and adverse events were detected by an open question. Contrary to our hypothesis, patients with adverse events (25.7%) gave higher estimates of future risk in the continuing medication setting. This association persisted in a multivariate analysis, where a number of factors related to adverse events and risk were controlled for (OR 1.76 (95% CI, 1.26-2.45), P=0.001 for the most highly correlated risk measure), but risk estimates did not differ between patients with and without adverse events in the setting of not continuing medication. Possible explanations for these findings are pre-existing differences in attitude towards drugs and level of fear of complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504624     DOI: 10.1038/sj.jhh.1001596

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Danish Physicians' Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative Study.

Authors:  Mikkel Lindskov Sachs; Morten Colding-Jørgensen; Per Helboe; Sofia Kälvemark Sporrong; Sven Frøkjaer; Katarina Jelic; Susanne Kaae
Journal:  Pharmaceut Med       Date:  2019-04

Review 2.  Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments.

Authors:  Beatriz Pérez-Escamilla; Lucía Franco-Trigo; Joanna C Moullin; Fernando Martínez-Martínez; José P García-Corpas
Journal:  Patient Prefer Adherence       Date:  2015-04-13       Impact factor: 2.711

3.  Developing an interactive mobile phone self-report system for self-management of hypertension. Part 1: patient and professional perspectives.

Authors:  Ulrika Bengtsson; Dick Kasperowski; Lena Ring; Karin Kjellgren
Journal:  Blood Press       Date:  2014-02-24       Impact factor: 2.835

4.  A psychosocial perspective of medication side effects, experiences, coping approaches and implications for adherence in hypertension management.

Authors:  Irene A Kretchy; Frances T Owusu-Daaku; Samuel A Danquah; Emmanuel Asampong
Journal:  Clin Hypertens       Date:  2015-09-17

5.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

6.  Phases in development of an interactive mobile phone-based system to support self-management of hypertension.

Authors:  Inger Hallberg; Charles Taft; Agneta Ranerup; Ulrika Bengtsson; Mikael Hoffmann; Stefan Höfer; Dick Kasperowski; Asa Mäkitalo; Mona Lundin; Lena Ring; Ulf Rosenqvist; Karin Kjellgren
Journal:  Integr Blood Press Control       Date:  2014-05-07

7.  Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Donald E Morisky
Journal:  Health Qual Life Outcomes       Date:  2013-11-06       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.